Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
(Basel) 13 (11), 379
Educational Disclaimer This content is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease
Key Clinical Point: STEMI = complete blockage + severe damage NSTEMI = partial blockage + less damage Both are life-threatening emergencies timely diagnosis and intervention save lives
ANSCHRIFT HERSTELLER IMPORTEUR INKO Internationale Handelskontor GmbH, Am Espan 1-3, 91154 Roth, Deutschland Mehr inkospor
Taken together, combining an SGLT-2 inhibitor with a GLP-1 receptor agonist in people with type 2 diabetes is associated with lower risk of major cardiovascular events, mortality, heart failure hospitalisations and adverse kidney outcomes compared with monotherapy based on a meta-analysis of 18 cohort studies with 1,164,774 participants [36]
Gastroenterology 124:A652, 2003
